Skip to main content
THERACRYF PLC logo

THERACRYF PLC — Investor Relations & Filings

Ticker · TCF ISIN · GB00BSVYN304 LEI · 213800NO3E6TSTQO8K20 IL Professional, scientific and technical activities
Open in API
Filings indexed 361 across all filing types
Latest filing 2021-07-13 Major Shareholding Noti…
Country GB United Kingdom
Listing IL TCF

About THERACRYF PLC

https://theracryf.com/

TheraCryf PLC is a clinical-stage therapeutics company focused on developing a new generation of innovative medicines for behavioural brain disorders and oncology. The company's research and development efforts are centered on sulforaphane-based compounds. Its primary therapeutic focus is on conditions such as opioid and alcohol abuse, binge eating disorder, anxiety, and fatigue. TheraCryf's business strategy is to generate compelling clinical data for its drug candidates with the goal of partnering its programs with larger pharmaceutical companies for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' for Evgen Pharma PLC. This is a regulatory requirement for shareholders to disclose when their voting rights cross specific thresholds. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2021-07-13 English
Early data for SFX-01 in leukaemia cell lines
Regulatory Filings Classification · 98% confidence The document is a press release issued via the London Stock Exchange's 'Reach' service, which is explicitly identified as a non-regulatory news service for corporate announcements. The content details preclinical research findings for the company's drug candidate, SFX-01. Since it does not fit into specific categories like financial reports, board changes, or dividend notices, and is a general corporate announcement of research progress, it falls under the 'Regulatory Filings' (RNS) category as the designated fallback for miscellaneous corporate announcements.
2021-07-13 English
Glioma Orphan Drug application submitted to US FDA
Regulatory Filings Classification · 98% confidence The document is an official announcement from Evgen Pharma plc regarding the submission of an Orphan Drug Designation Request to the FDA. It is distributed via the Regulatory News Service (RNS) of the London Stock Exchange. Since it is a corporate announcement regarding regulatory progress and does not fit into specific categories like financial reports, M&A, or dividends, it is classified as a general regulatory filing.
2021-07-13 English
Second Price Monitoring Extn
Regulatory Filings Classification · 100% confidence The document is a 'Price Monitoring Extension' notice issued via the London Stock Exchange's RNS (Regulatory News Service). It is a short, automated regulatory notification regarding market mechanics (auction call period extension) rather than a financial report, management update, or corporate action. As it does not fit into specific categories like M&A, dividends, or share issues, it falls under the general regulatory filing category.
2021-07-09 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is a 'Price Monitoring Extension' notice issued via the London Stock Exchange's RNS (Regulatory News Service). It describes a technical market mechanism (auction call extension) rather than a financial report, management change, or corporate action. Since it does not fit into specific categories like dividends, share issues, or earnings, it falls under the general regulatory announcement category.
2021-07-09 English
Interim Safety and Futility Analysis - STAR trial
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from Evgen Pharma PLC regarding the results of an interim safety and futility analysis for a clinical trial (STAR COVID-19). It is a corporate announcement detailing clinical trial outcomes, which does not fit into specific categories like financial reports, dividends, or board changes. As it is a general regulatory announcement provided via the London Stock Exchange's RNS service, it falls under the 'Regulatory Filings' category.
2021-07-09 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.